Chang-Fu Kuo

TL;DR: Data from epidemiological studies from diverse regions of the world are synthesized to depict the geographic variation in gout prevalence and incidence, and indicate that the distribution of gout is uneven across the globe, with prevalence being highest in Pacific countries.

TL;DR: Trends in the epidemiology of gout and patterns of urate-lowering treatment (ULT) in the UK general population from 1997 to 2012 are described and patient adherence has improved during the study period, but it remains poor.

TL;DR: Use of non–vitamin K oral anticoagulants with or without concurrent use of atorvastatin, digoxin, and erythromycin or clarithromycin compared with the use of NOACs alone was associated with increased risk of major bleeding, and concurrent use of amiodarone, fluconazole, rifampin, and phenytoin with NOacs had a significant increase in adjusted incidence rates.

TL;DR: The individual risks of SLE and other autoimmune diseases were increased in families that included patients with SLE as well as the relative contributions of heritability, shared, and nonshared environmental factors to SLE susceptibility.

TL;DR: This study demonstrates a link of gout, not hyperuricaemia, with a higher risk of death from all causes and cardiovascular diseases.